Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Interaction between hepatic membrane type 1 matrix metalloproteinase and acireductone dioxygenase 1 regulates hepatitis C virus infection.

Chang ML, Huang YH, Cheng JC, Yeh CT.

J Viral Hepat. 2016 Apr;23(4):256-66. doi: 10.1111/jvh.12486. Epub 2015 Nov 5.

PMID:
26537061
2.

293 cells over-expressing human ADI1 and CD81 are permissive for serum-derived hepatitis C virus infection.

Cheng JC, Yeh YJ, Pai LM, Chang ML, Yeh CT.

J Med Virol. 2009 Sep;81(9):1560-8. doi: 10.1002/jmv.21495.

PMID:
19626614
3.

Increased intrahepatic cyclooxygenase 2, matrix metalloproteinase 2, and matrix metalloproteinase 9 expression is associated with progressive liver disease in chronic hepatitis C virus infection: role of viral core and NS5A proteins.

Núñez O, Fernández-Martínez A, Majano PL, Apolinario A, Gómez-Gonzalo M, Benedicto I, López-Cabrera M, Boscá L, Clemente G, García-Monzón C, Martín-Sanz P.

Gut. 2004 Nov;53(11):1665-72.

4.

Infection of Human Liver Myofibroblasts by Hepatitis C Virus: A Direct Mechanism of Liver Fibrosis in Hepatitis C.

Aoudjehane L, Bisch G, Scatton O, Granier C, Gaston J, Housset C, Roingeard P, Cosset FL, Perdigao F, Balladur P, Wakita T, Calmus Y, Conti F.

PLoS One. 2015 Jul 27;10(7):e0134141. doi: 10.1371/journal.pone.0134141. eCollection 2015.

5.

Serum and liver HCV RNA levels in patients with chronic hepatitis C: correlation with clinical and histological features.

De Moliner L, Pontisso P, De Salvo GL, Cavalletto L, Chemello L, Alberti A.

Gut. 1998 Jun;42(6):856-60.

6.

Distribution of hepatitis C virus infection in liver biopsies from children and adults with chronic hepatitis C.

de Lucas S, Bartolomé J, Rodríguez-Iñigo E, Casqueiro M, Millán A, Ruiz-Moreno M, Oliva H, Carreño V.

J Med Virol. 2001 May;64(1):1-5.

PMID:
11285561
7.
8.

Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection.

Haydon GH, Jarvis LM, Blair CS, Simmonds P, Harrison DJ, Simpson KJ, Hayes PC.

Gut. 1998 Apr;42(4):570-5.

9.

Intrahepatic hepatitis C virus RNA quantification in microdissected hepatocytes.

Vona G, Tuveri R, Delpuech O, Vallet A, Canioni D, Ballardini G, Baptiste Trabut J, Le Bail B, Nalpas B, Carnot F, Pol S, Brechot C, Thiers V.

J Hepatol. 2004 Apr;40(4):682-8.

PMID:
15030986
10.

Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection.

Hsu CS, Liu CH, Liu CJ, Wang CC, Chen CL, Lai MY, Chen PJ, Chen DS, Kao JH.

Am J Gastroenterol. 2009 Mar;104(3):598-604. doi: 10.1038/ajg.2008.125. Epub 2009 Feb 10.

PMID:
19262519
12.

Non-structural 3 protein expression is associated with T cell protein tyrosine phosphatase and viral RNA levels in chronic hepatitis C patients.

Rahbin N, Frelin L, Aleman S, Hultcrantz R, Sällberg M, Brenndörfer ED.

Biochem Biophys Res Commun. 2013 Mar 29;433(1):31-5. doi: 10.1016/j.bbrc.2013.02.075. Epub 2013 Feb 27.

PMID:
23454379
13.

Intrahepatic hepatitis C virus replication correlates with chronic hepatitis C disease severity in vivo.

Pal S, Shuhart MC, Thomassen L, Emerson SS, Su T, Feuerborn N, Kae J, Gretch DR.

J Virol. 2006 Mar;80(5):2280-90.

14.

Detection of widespread hepatocyte infection in chronic hepatitis C.

Agnello V, Abel G, Knight GB, Muchmore E.

Hepatology. 1998 Aug;28(2):573-84.

PMID:
9696027
15.

Claudin promotes activation of pro-matrix metalloproteinase-2 mediated by membrane-type matrix metalloproteinases.

Miyamori H, Takino T, Kobayashi Y, Tokai H, Itoh Y, Seiki M, Sato H.

J Biol Chem. 2001 Jul 27;276(30):28204-11. Epub 2001 May 29.

16.

Role of hepatic HCV-RNA level on the severity of chronic hepatitis C and response to antiviral therapy.

Maylin S, Laouénan C, Martinot-Peignoux M, Panhard X, Lapalus M, Nicolas-Chanoine MH, Bedossa P, Asselah T, Marcellin P.

J Clin Virol. 2012 Jan;53(1):43-7. doi: 10.1016/j.jcv.2011.09.029. Epub 2011 Nov 17.

PMID:
22099210
17.

Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.

Petit JM, Benichou M, Duvillard L, Jooste V, Bour JB, Minello A, Verges B, Brun JM, Gambert P, Hillon P.

Am J Gastroenterol. 2003 May;98(5):1150-4.

PMID:
12809841
19.

Expression profiles of genes associated with viral entry in HCV-infected human liver.

Nakamuta M, Fujino T, Yada R, Aoyagi Y, Yasutake K, Kohjima M, Fukuizumi K, Yoshimoto T, Harada N, Yada M, Kato M, Kotoh K, Taketomi A, Maehara Y, Nakashima M, Enjoji M.

J Med Virol. 2011 May;83(5):921-7. doi: 10.1002/jmv.22042.

PMID:
21412800
20.

Intracellular expression of the proliferative marker Ki-67 and viral proteins (NS3, NS5A and C) in chronic, long lasting hepatitis C virus (HCV) infection.

Kasprzak A, Adamek A, Biczysko W, Seidel J, Przybyszewska W, Olejniczak K, Juszczyk J, Zabel M.

Folia Histochem Cytobiol. 2007;45(4):357-66.

Supplemental Content

Support Center